EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 156 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,446 | -18.9% | 408,758 | 0.0% | 0.02% | -16.7% |
| Q2 2023 | $7,946 | +14.9% | 408,758 | +67.7% | 0.02% | +12.5% |
| Q1 2023 | $6,915 | +56.2% | 243,736 | +61.0% | 0.02% | +60.0% |
| Q4 2022 | $4,426 | -97.1% | 151,418 | +4503.8% | 0.01% | – |
| Q4 2020 | $153,000 | -73.9% | 3,289 | -76.2% | 0.00% | -100.0% |
| Q3 2020 | $586,000 | -92.8% | 13,800 | -91.8% | 0.00% | -94.1% |
| Q2 2020 | $8,084,000 | -45.1% | 168,501 | -47.4% | 0.02% | -52.8% |
| Q1 2020 | $14,730,000 | -33.6% | 320,227 | -13.3% | 0.04% | +2.9% |
| Q4 2019 | $22,180,000 | -15.1% | 369,177 | -20.0% | 0.04% | -18.6% |
| Q3 2019 | $26,110,000 | +16.0% | 461,558 | +14.1% | 0.04% | +19.4% |
| Q2 2019 | $22,515,000 | +78.4% | 404,369 | +61.7% | 0.04% | +80.0% |
| Q1 2019 | $12,622,000 | +276.2% | 250,004 | +200.2% | 0.02% | +233.3% |
| Q4 2018 | $3,355,000 | -45.8% | 83,289 | -6.8% | 0.01% | -33.3% |
| Q3 2018 | $6,194,000 | -86.2% | 89,341 | -84.9% | 0.01% | -87.1% |
| Q2 2018 | $44,839,000 | -0.9% | 592,642 | -31.0% | 0.07% | -2.8% |
| Q1 2018 | $45,268,000 | +15.5% | 859,142 | +17.1% | 0.07% | +16.1% |
| Q4 2017 | $39,200,000 | +188.6% | 733,822 | +222.1% | 0.06% | +181.8% |
| Q3 2017 | $13,585,000 | – | 227,794 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |